MedPath
NMPA Approval

Sildenafil Citrate Orodispersible Tablets

国药准字H20254049

April 30, 2025

Drug Information

枸橼酸西地那非口崩片

片剂

50mg(按C₂₂H₃₀N₆O₄S计)

化学药品

April 30, 2025

Company Information

Applicant Company

广东省广州市黄埔区神舟路288号C栋1001房

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸西地那非口崩片 - NMPA 批准文号 | MedPath